BridgeBio Pharma quarterly revenue jumps 193% to $353.2 million
BridgeBio Pharma's revenue growth is speeding up. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
74.36▲ +5.14%
Latest · 2026-10-30
BridgeBio Pharma's revenue growth is speeding up. Results for the quarter ended September 30, 2026, from the earnings release filed with the SEC on Oct 29, 2026.
2026-10-30